tiprankstipranks
Trending News
More News >
Kiniksa Pharmaceuticals (KNSA)
NASDAQ:KNSA
US Market

Kiniksa Pharmaceuticals (KNSA) Income Statement

Compare
542 Followers

Kiniksa Pharmaceuticals Income Statement

Last quarter (Q3 2025), Kiniksa Pharmaceuticals's total revenue was $180.85M, an increase of 61.17% from the same quarter last year. In Q3, Kiniksa Pharmaceuticals's net income was $18.43M. See Kiniksa Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 423.24M$ 270.26M$ 220.18M$ 38.54M$ 0.00
Gross Profit
$ 362.33M$ 213.74M$ 197.28M$ 29.44M$ -3.81M
Operating Expenses
$ 407.94M$ 238.93M$ 187.51M$ 186.08M$ 153.56M
Depreciation and Amortization
$ 1.70M$ 2.34M$ 2.40M$ 2.35M$ 3.81M
EBITDA
$ -43.92M$ -22.86M$ 12.18M$ -154.28M$ -152.42M
Operating Income
$ -45.62M$ -25.20M$ 9.77M$ -156.64M$ -157.36M
Other Income/Expenses
$ 9.46M$ 8.54M$ 1.25M$ 97.00K$ 1.13M
Pretax Income
$ -36.15M$ -16.65M$ 11.03M$ -156.54M$ -156.23M
Net Income
$ -43.19M$ 14.08M$ 183.36M$ -157.92M$ -161.38M
Per Share Metrics
Basic EPS
$ -0.60$ 0.20$ 2.64$ -2.30$ -2.61
Diluted EPS
$ -0.60$ 0.20$ 2.60$ -2.30$ -2.61
Weighted Average Shares Outstanding
71.42M 70.06M 69.38M 68.58M 61.84M
Weighted Average Shares Outstanding (Diluted)
71.42M 71.92M 70.42M 68.58M 61.84M
Currency in USD

Kiniksa Pharmaceuticals Earnings and Revenue History